| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |